Kathleen D. Scott - 29 Sep 2023 Form 3 Insider Report for NKGen Biotech, Inc. (NKGN)

Role
Director
Signature
/s/ Pierre Gagnon, Attorney-in-fact
Issuer symbol
NKGN
Transactions as of
29 Sep 2023
Net transactions value
$0
Form type
3
Filing time
10 Oct 2023, 16:14:08 UTC
Previous filing
05 Jan 2023
Next filing
04 Jan 2024

No securities are beneficially owned.

Remarks:

See attached Exhibit 24 - Power of Attorney